Correlation Between Creo Medical and Quadrise Plc

Can any of the company-specific risk be diversified away by investing in both Creo Medical and Quadrise Plc at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Creo Medical and Quadrise Plc into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Creo Medical Group and Quadrise Plc, you can compare the effects of market volatilities on Creo Medical and Quadrise Plc and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Creo Medical with a short position of Quadrise Plc. Check out your portfolio center. Please also check ongoing floating volatility patterns of Creo Medical and Quadrise Plc.

Diversification Opportunities for Creo Medical and Quadrise Plc

0.58

Correlation Coefficient

Creo Medical  Quadrise Plc

Very weak diversification

The 3 months correlation between Creo and Quadrise is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Creo Medical Group and Quadrise Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quadrise Plc and Creo Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Creo Medical Group are associated (or correlated) with Quadrise Plc. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quadrise Plc has no effect on the direction of Creo Medical i.e., Creo Medical and Quadrise Plc go up and down completely randomly.

Pair Corralation between Creo Medical and Quadrise Plc

Assuming the 90 days trading horizon Creo Medical is expected to generate 90.08 times less return on investment than Quadrise Plc. But when comparing it to its historical volatility, Creo Medical Group is 2.01 times less risky than Quadrise Plc. It trades about 0.0 of its potential returns per unit of risk. Quadrise Plc is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  342.00  in Quadrise Plc on December 4, 2024 and sell it today you would earn a total of  48.00  from holding Quadrise Plc or generate 14.04% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Creo Medical Group  vs.  Quadrise Plc

Creo Medical Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Creo Medical Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Creo Medical is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Quadrise Plc

Risk-Adjusted Performance

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Quadrise Plc are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, Quadrise Plc exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Creo Medical and Quadrise Plc

The main advantage of trading using opposite Creo Medical and Quadrise Plc positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Creo Medical position performs unexpectedly, Quadrise Plc can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quadrise Plc will offset losses from the drop in Quadrise Plc's long position.

The idea behind Creo Medical Group and Quadrise Plc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.